Frank E Thomas Larimar Therapeutics, Inc. (LRMR) insider trading activity

LRMR Quotes by TradingView

Frank E Thomas is Director of Larimar Therapeutics, Inc.. Currently has a direct ownership of 2,000 shares of LRMR, which is worth approximately $11,820. The most recent transaction as insider was on Feb 14, 2024, when has been sold 2,000 shares (Common Stock) at a price of $11.0 per share, resulting in proceeds of $22,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2K
0% 3M change
n/a 12M change
Total Value Held $11,820

FRANK E THOMAS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2024
BUY
Open market or private purchase
$22,000 $11.0 p/Share
2,000 Added 50.0%
2,000 Common Stock

Also insider at

SPRO
Spero Therapeutics, Inc. Healthcare
ORTX
Orchard Therapeutics plc Healthcare
FET

Frank E Thomas

Director
Cambridge, MA

Track Institutional and Insider Activities on LRMR

Follow Larimar Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LRMR shares.

Notify only if

Insider Trading

Get notified when an Larimar Therapeutics, Inc. insider buys or sells LRMR shares.

Notify only if

News

Receive news related to Larimar Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LRMR